Sort
261,768 grants matching “gene therapy”
MITOCHONDRIAL ETIOLOGIES OF PARKINSON'S DISEASE
$1,119,108University Of Virginia Charlottesville · P50 · FY2001 · NS
Proteogenomic Characterization of Tumor Tissues and Preclinical Models with High Precision
$1,119,051Hui Zhang · Johns Hopkins University · U24 · FY2023 · CA
Pathogenesis and treatment of NOMID, DIRA and other autoinflammatory diseases
$1,119,036Raphaela Goldbach-Mansky · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2011 · AR
Mechanisms Responsible for Impairment of Neocortical Development by Cocaine
$1,119,033William Freed · National Institute On Drug Abuse · ZIA · FY2010 · DA
Recombinant AAV for Correction of Genetic Abnormalities
$1,118,918Barry J. Byrne · University Of Florida · P01 · FY2009 · DK
Innovating Yeast and Human Genetics Approaches to Define Mechanisms of Neurodegenerative Disease
$1,118,773Aaron D. Gitler · Stanford University · R35 · FY2023 · NS
Sequelae of Hip Fracture in Men: An Epidemiologic Study
$1,118,752Jay Steven Magaziner · University Of Maryland Baltimore · R37 · FY2007 · AG
Cannabidiol/Palmitoylethanolamide sublingual tablets for the treatment of Painful Diabetic Peripheral Neuropathy
$1,118,712Debra Kimless · Pure Green Pharmaceuticals, Inc. · R44 · FY2023 · DK
Novel Biologic Therapies for GVHD
$1,118,541Leslie S Kean · Boston Children'S Hospital · R01 · FY2024 · HL
GDNF Delivery to MPTP Monkeys by EIAV lentivirus and AAV
$1,118,454Yale University · U01 · FY2004 · NS
Hibernation--a New Approach To Stroke Therapy
$1,118,431John Hallenbeck · National Institute Of Neurological Disorders And Stroke · ZIA · FY2009 · NS
A Synapse-Protecting Small Peptide to Treat a-Syn/Tau Mixed Proteinopathies in Alzheimer's Disease Related Dementias (ADRD)
$1,118,107Michael R Ruff · Creative Bio-Peptides, Inc. · R44 · FY2025 · AG
Metal Chelators and Thiols in Endothelial Function
$1,118,075Oregon State University · P01 · FY2004 · AT
Development of an LXR agonist as first in class therapy for treatment of metastatic melanoma
$1,117,983Isabel Kurth · Rgenix, Inc. · R44 · FY2016 · CA
Refanalin for lung preservation and transplantation
$1,117,921Prakash Narayan · Angion Biomedica Corporation · R44 · FY2009 · HL
Immunobiology and immunotherapy of leukemia
$1,117,867Austin J Barrett · National Heart, Lung, And Blood Institute · ZIA · FY2017 · HL
Characterization and improvement of graft versus leukemia effects
$1,117,867Austin J Barrett · National Heart, Lung, And Blood Institute · ZIA · FY2017 · HL
Development Of Theoretical Methods For Studying Biological Macromolecules
$1,117,834Bernard R Brooks · National Heart, Lung, And Blood Institute · ZIA · FY2023 · HL
Asthma and Allergic Diseases Cooperative Research Center
$1,117,829Yong-Jun Liu · University Of Tx Md Anderson Can Ctr · U19 · FY2009 · AI
Multi-Ethnic Translational Research Optimization (METRO) Lupus Consortium
$1,117,810Jill P Buyon · New York University School Of Medicine · UH2 · FY2019 · AR
Broad Spectrum Neutralizing Human Abs to SARS and Related Coronaviruses
$1,117,743Wayne A. Marasco · Dana-Farber Cancer Inst · R01 · FY2011 · AI
Xenobiotic receptors
$1,117,669Frank J Gonzalez · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Gene regulatory elements, networks, and mechanisms
$1,117,633Raja Jothi · National Institute Of Environmental Health Sciences · ZIA · FY2013 · ES
UCSF COVID-19: Extended Immunophenotyping Studies
$1,117,573David J Erle · University Of California, San Francisco · U19 · FY2020 · AI
Beyond the Type-2 High Endotype
$1,117,573Prescott G Woodruff · University Of California, San Francisco · U19 · FY2020 · AI